Free Trial

869 Shares in Chemed Co. (NYSE:CHE) Bought by Blueshift Asset Management LLC

Chemed logo with Medical background
Remove Ads

Blueshift Asset Management LLC purchased a new stake in Chemed Co. (NYSE:CHE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 869 shares of the company's stock, valued at approximately $460,000.

Several other institutional investors have also added to or reduced their stakes in the company. Pathstone Holdings LLC increased its holdings in shares of Chemed by 6.0% during the third quarter. Pathstone Holdings LLC now owns 3,694 shares of the company's stock worth $2,220,000 after purchasing an additional 210 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Chemed in the third quarter valued at about $310,000. Commerce Bank raised its stake in Chemed by 0.6% during the third quarter. Commerce Bank now owns 6,207 shares of the company's stock worth $3,730,000 after acquiring an additional 40 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Chemed in the third quarter worth about $3,835,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Chemed by 8.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company's stock valued at $73,792,000 after purchasing an additional 9,178 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Brian C. Judkins purchased 145 shares of the firm's stock in a transaction on Monday, December 30th. The shares were acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the acquisition, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.32% of the company's stock.

Remove Ads

Chemed Stock Performance

Shares of NYSE:CHE traded up $1.65 during midday trading on Tuesday, hitting $608.54. 123,742 shares of the stock were exchanged, compared to its average volume of 89,101. The business's 50-day moving average price is $569.25 and its 200 day moving average price is $565.58. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $648.29. The stock has a market capitalization of $8.91 billion, a price-to-earnings ratio of 30.75, a P/E/G ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed's payout ratio is 10.05%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CHE. Royal Bank of Canada upped their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Read Our Latest Research Report on CHE

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads